Author:
Zhai Guihua,Grubbs Clinton J.,Stockard Cecil R.,Umphrey Heidi R.,Beasley T. Mark,Kim Hyunki
Publisher
Public Library of Science (PLoS)
Reference33 articles.
1. Tamoxifen metabolism and its effect on endocrine treatment of breast cancer;S Briest;Clin Adv Hematol Oncol,2009
2. An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer;KL Henriksen;Acta Oncol,2009
3. Fulvestrant–a novel estrogen receptor antagonist for the treatment of advanced breast cancer;AU Buzdar;Drugs Today (Barc),2008
4. Oestrogen receptor beta and neoadjuvant therapy with tamoxifen: prediction of response and effects of treatment;WR Miller;Br J Cancer,2006
5. Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients;DP Rose;Cancer Res,1992
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献